Abstract
McArdle disease is a glycogen storage myopathy which is caused by mutations in the PYGM gene with resultant myophosphorylase deficiency. Patients with McArdle disease typically present with exercise intolerance and recurrent rhabdomyolysis. These patients may also manifest fixed proximal limb weakness and persistent CK elevation. Muscle biopsy is useful to differentiate McArdle disease from other metabolic myopathies, such as other glycogen storage myopathies, lipid storage myopathies, and mitochondrial myopathies, to direct genetic testing. Here we present a patient with McArdle disease who was initially misdiagnosed with inflammatory myopathy and was unnecessarily exposed to immunosuppressive therapies. A correct diagnosis was achieved by a muscle biopsy, which led to appropriate management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.